60th Annual Meeting of the Japanese Society of Neurology

Session information

Print

Symposium

[S-04] Update on Diagnostic Biomarkers for the early diagnosis of Alzheimer's Disease

Wed. May 22, 2019 1:20 PM - 3:20 PM Room 1 (Osaka International Convention Center 5F Large Hall)

Chair:Takeshi Iwatsubo(Department of Neuropathology, School of Medicine, The University of Tokyo, Japan), Hisatomo Kowa(Kobe University Graduate School of Health Sciences, Japan)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-1] Updates on PET imaging of tau pathologies

Makoto Higuchi (National Institutes for Quantum and Radiological Science and Technology, Japan)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-2] Plasma Abeta as a biomarker for Alzheimer's disease

Koichi Tanaka (Koichi Tanaka Mass Spectrometry Research Laboratory Shimadzu Corporation, Japan)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-3] TRC-PAD: Accelerating Recruitment in AD Clinical Trials via Innovation in Information Technology

Gustavo A. Jimenez-Maggiora1, Rema Raman1, Michael S. Rafii1, Reisa A. Sperling2,3, Jeffrey L. Cummings4, Paul S. Aisen1 (1.Alzheimer's Therapeutics Research Institute, University of Southern California, USA, 2.Department of Neurology, Massachusetts General Hospital, Harvard Medical School, USA, 3.Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Harvard Medical School, USA, 4.Cleveland Clinic Lou Ruvo Center for Brain Health, USA)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-4] Japanese ADNI: from biomarkers to disease-modifying therapy

Takeshi Iwatsubo (Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Japan)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.